Taiwan’s Tanvex Welcomes US Filgrastim Approval – After String Of CRLs
Will Compete With Sandoz, Pfizer, Amneal Filgrastim Biosimilars
Tanvex Biopharma submitted an application for biosimilar filgrastim as far back as 2018. Now, after multiple setbacks, the firm has celebrated becoming a commercial-stage company in the US.
